Integra LifeSciences | IART - Pre Tax Profit


Integra LifeSciences reported $-6.82M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
CONMED USD 4.27M 25.65M Sep/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
HeartBeam USD -5.25M 280K Sep/2025
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Orthofix International USD -2.19M 20.07M Dec/2025
Smith & Nephew USD 469M 70M Dec/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025